Black patients face a lower likelihood of receiving life-saving kidney transplants compared to their non-Black counterparts.

In the heart of New York City, a significant step forward was taken in 2023 to address a long-standing issue in the healthcare system. The transplant authority and the state legislature passed groundbreaking legislation aimed at increasing live-donor kidney transplants for marginalized communities, particularly Black, Latino, and Native American patients.

This move comes at a critical time, as data reveals a stark disparity in the rates of end-stage kidney disease and live-donor kidney transplantation between these groups and their White counterparts. Black individuals, for instance, have an almost four times higher rate of end-stage kidney disease but their rate of live-donor kidney transplantation is more than four times lower.

One of the key issues highlighted by this disparity is the fact that family members of Black patients are often unable to donate due to their own health issues related to end-stage kidney disease. This issue is further compounded by the fact that living in racially and ethnically segregated neighborhoods is associated with worse outcomes after kidney transplants for Black patients.

To address this, New York state adopted a law providing direct reimbursement of up to $10,000 to living organ donors for expenses not covered by insurance. Similarly, in New York City, legislation was passed that provides direct compensation of up to $10,000 for living organ donors to cover costs not covered by insurance. These measures are intended to encourage more donors, particularly in a state where New York has one of the country's lowest rates of registered organ donors.

The story of Marc Thompson and his cousin Macey Levan serves as a powerful testament to the impact of this legislation. Marc, who suffered from leg cramps, itching, trouble sleeping, daily weight gain, and fluid retention due to dialysis, received a kidney transplant in 2008, thanks to Macey's selfless act. After the transplant, Marc was able to continue his passion as a journalist and thrive.

Macey, who underwent a complex process to donate her kidney to Marc in 2009, has since dedicated her career to improving access to kidney transplants from live donors for marginalized groups and reducing the barriers to donation. She was recently elected vice president of patient and donor affairs for the Organ Procurement and Transplantation Network.

However, the fight is far from over. Structural racism and residential segregation remain significant barriers to live-donor kidney transplantation and broader health care access for minoritized groups. The public health system must develop national and local policies that invest in residential neighborhoods and provide funding for medical centers in resource-poor and segregated neighborhoods.

Moreover, the public health and clinical communities must study the mechanisms linking segregation to poor access to health care and identify interventions that improve access for minoritized groups. Identifying racial disparities without addressing racism will not achieve health equity in live-donor kidney transplantation.

As we move forward, the story of Marc Thompson and Macey Levan serves as a beacon of hope, demonstrating the transformative power of live-donor kidney transplants and the importance of addressing the systemic barriers that prevent marginalized communities from accessing this life-saving treatment.

Black patients face a lower likelihood of receiving life-saving kidney transplants compared to their non-Black counterparts.